Dr. Agarwal on Second-Line Therapy Selection in Metastatic RCC
January 4th 2019Neeraj Agarwal, MD, associate professor, Division of Oncology, Department of Medicine, University of Utah School of Medicine, Huntsman Cancer Institute, discusses second-line therapy selection in metastatic renal cell carcinoma.